# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The European Commission launches probe into Zoetis over alleged market interference in dog pain medication launch. Focus on Zoe...
Wall Street witnessed one of the worst sessions since the beginning of the year, with widespread declines across the board as s...
Zoetis' Q4 2023 performance with $2.21 billion revenue, 8% YoY growth, and strong sales in companion animal products.